Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.

Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.

This product is a third-generation cephalosporin antibiotic. It has high antibacterial activity against Escherichia coli, Klebsiella pneumoniae and other Enterobacteriaceae, Haemophilus influenzae, Pseudomonas aeruginosa, etc. It also has good antibacterial effects on nitrate-negative bacilli, Alcaligenes, etc. Most beta-lactamases produced by bacteria are highly stable, so it can still have antibacterial activity against multi-drug resistant strains of the vast majority of Gram-negative bacilli mentioned above. Gram-positive cocci such as pneumococci and hemolytic streptococci are highly sensitive to this product, but this product has only moderate activity against staphylococci, while enterococci and methicillin-resistant Staphylococci are often resistant to this product. This product has certain antibacterial activity against anaerobic bacteria such as Peptococcus and Peptostreptococci, but has poor antibacterial effect against Bacteroides fragilis. Its mechanism of action is to bind to penicillin-binding proteins (PBPs) on the bacterial cell membrane, acylate the transpeptidase, inhibit the synthesis of the bacterial septum and cell wall, affect the cross-linking of the cell wall mucopeptide components, inhibit cell division and growth, elongate the bacterial morphology, and finally dissolve and die.

This product is a β-lactamase-stable cephalosporin bactericidal antibiotic. It works by blocking the synthesis of the main cell wall polymer-peptidoglycan. Because it can quickly penetrate the bacterial cell wall and bind to the target enzyme (penicillin binding protein) with high affinity, it can kill a wide spectrum of Gram-negative and Gram-positive pathogens at low concentrations. This has been confirmed in many in vitro studies on hospital- and community-acquired pathogens worldwide, and recent studies have shown that its sensitivity has not changed. Many strains resistant to other injectable cephalosporins or aminoglycosides are still sensitive to this product.

This product is a β-lactamase-stable cephalosporin bactericidal antibiotic. It works by blocking the synthesis of the main cell wall polymer - peptidoglycan. Because it can quickly penetrate the bacterial cell wall and bind to the target enzyme (penicillin binding protein) with high affinity, it can have a bactericidal effect on a fairly broad spectrum of Gram-negative and Gram-positive pathogens at low concentration levels. This has been confirmed in numerous in vitro studies on hospital- and community-acquired pathogens worldwide, and recent studies have shown that its sensitivity has not changed. Many strains that are resistant to other injectable cephalosporins or aminoglycosides are still sensitive to this product. Antibacterial activity: The following are pathogens that are sensitive to cefpirome in vitro: Gram-positive bacteria: Staphylococcus aureus (including